RELEASE DATE:  November 10, 2003


National Institute of Allergy and Infectious Diseases (NIAID)

RECEIPT DATE:  February 19, 2004


The Division of Acquired Immune Deficiency Syndrome (DAIDS) of the National 
Institute of Allergy and Infectious Diseases (NIAID), National Institutes of 
Health (NIH), has a requirement for the development of efficacious 
preventative and therapeutic vaccines against HIV/AIDS for worldwide use in 
stemming the AIDS epidemic.  To augment the vaccine product pipeline, we are 
seeking opportunities to advance vaccine concepts toward the product stage 
via a focused, development-based approach.  Specifically, the long-range goal 
of this solicitation is the development of new safe and immunogenic vaccine 
candidates that merit further evaluation in larger human trials. The HIV 
Vaccine Design and Development Teams (HVDDT) solicitation seeks to fund 
consortia of scientists with development experience from industry and/or 
academia that have 1) identified a promising vaccine concept, and 2) devised 
a plan for its targeted development into a vaccine product.  A vaccine 
product is defined here to be a material and its manner of administration 
that could reasonably provide protection against AIDS.  Offerors are 
encouraged, but not required to conduct phase I/II trials in collaboration 
with NIAID/DAIDS-supported HIV/AIDS vaccine trials networks.  Support for 
phase III studies will not be funded under this solicitation. 

It is anticipated that up to four (4) cost reimbursement, completion type 
contracts will be awarded for a period of five (5) years, beginning 
approximately September 30, 2004.  RFP-NIH-NIAID-DAIDS-04-42 will be 
available electronically on or about November 18, 2003, and may be accessed 
through the NIAID Contract Management Branch (CMB) Home Page by using the 
following electronic address and instructions: NIAID/CMB Home Page (via the 
World Wide Web): Access by using http://www.niaid.nih.gov/contract and select 
the “RFPs” link and then select “RFP-NIH-NIAID-DAIDS-04-42.”  It will also be 
posted on FedBizOpps at http://www.fedbizopps.gov/.

Please note that the RFP for this acquisition has been revised to include 
only the Work Statement, deliverable and reporting requirements, special 
requirements and mandatory qualification, if any, the Technical Evaluation 
Criteria, and the proposal preparation instructions.  All information 
required for the submission of an offer will be contained in the electronic 
RFP package.  Following proposal submission and the initial review process, 
Offerors comprising the competitive range will be requested to provide 
additional documentation to the Contracting Officer.

Responses to this RFP will be due on February 19, 2004.  Any responsible 
Offeror may submit a proposal that will be considered by the Government.  

This advertisement does not commit the Government to award a contract.  No 
collect calls will be accepted.

Contracting Office Address:

Department of Health and Human Services
National Institutes of Health
National Institutes of Allergy and Infectious Diseases
Contract Management Branch 
6700-B Rockledge Drive
Room 2230, MSC 7612 
Bethesda, MD, 20892-7612

Point of Contact:

Janet M. Mattson, Contracting Officer, Phone 301-496-0993, Fax 301-480-5253, 
Email: jm32u@nih.gov

Return to Volume Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.